Biodesix, Inc. (BDSX) vs Quantum Cyber N.V (QUCY)

Biodesix, Inc. and Quantum Cyber N.V are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $260.7M against $95.1M — 2.7× the size. Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against 34.5%. Quantum Cyber N.V has the higher net margin (0.00% vs −27.0%) and the lower return on invested capital (−194.0% vs −49.6%). Across the 18 metrics below, Biodesix, Inc. leads on 9 and Quantum Cyber N.V on 9.

Valuation

Metric BDSX QUCY Diagnostics & Research median
P/E n/m n/m 35.56
P/S 2.37 21.53 4.37
P/B 26.64 0.95 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 2.53 8.36 5.51
Earnings yield (13.40%) (1,121.13%) (1.89%)
Free cash flow yield (8.37%) (86.11%) (0.15%)

Profitability

Metric BDSX QUCY Diagnostics & Research median
Gross margin 82.50% 56.91% 50.89%
Operating margin (20.02%) 0.00% (8.57%)
Net margin (26.97%) 0.00% (6.37%)
Free cash flow margin (19.82%) 0.00% 0.00%
Return on equity (540.01%) (325.19%) (2.92%)
Return on assets (30.33%) (165.20%) (6.71%)
Return on invested capital (49.60%) (193.99%) 0.00%

Growth

Metric BDSX QUCY Diagnostics & Research median
Revenue growth (TTM) 34.46% 68.99% 7.69%
EPS growth (last fiscal year) 29.24% 87.92% 25.92%
Revenue growth, 5-year CAGR 14.20% 1.70% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX QUCY Diagnostics & Research median
Debt to equity 5.12 0.00 0.11
Current ratio 2.85 5.56 2.02
Net debt to EBITDA (1.36) (0.01) 0.70

Dividend

Metric BDSX QUCY Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BDSX QUCY Diagnostics & Research median
Market cap 260.72m 95.07m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack